During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Christopher Reyes, CEO, Co-Founder and Director at Bloom Science, about the new class of microbe-based therapeutics for neurological disorders the company is working on.